Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
5.15
-0.10 (-1.90%)
At close: Feb 12, 2026, 4:00 PM EST
5.15
0.00 (0.00%)
Pre-market: Feb 13, 2026, 7:00 AM EST
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $167.49 million as of February 13, 2026. Its market cap has increased by 28.45% in one year.
Market Cap
167.49M
Enterprise Value
42.10M
1-Year Change
28.45%
Ranking
Category
Stock Price
$5.15
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $167.49M, a decrease of -52.79%. That is a compound annual growth rate of -25.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 167.49M | -13.01% |
| Dec 31, 2025 | 192.53M | 32.89% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galectin Therapeutics | 177.94M |
| C4 Therapeutics | 176.38M |
| Milestone Pharmaceuticals | 176.25M |
| Karyopharm Therapeutics | 173.86M |
| Tiziana Life Sciences | 172.31M |
| Kalaris Therapeutics | 170.94M |
| Molecular Partners AG | 170.90M |
| Editas Medicine | 167.42M |